Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors

Radiation-Induced IFN-  Production within the Tumor Microenvironment Influences Antitumor Immunity

(2014) A. A. Lugade et al.   JOURNAL OF IMMUNOLOGY

Generation of a Dual-Functioning Antitumor Immune Response in the Peritoneal Cavity

(2013) Abigail L. Sedlacek et al.   AMERICAN JOURNAL OF PATHOLOGY

IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor

(2013) Scott A. Gerber et al.   AMERICAN JOURNAL OF PATHOLOGY

Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients

(2013) Lovisa Farnebo et al.   INTERNATIONAL JOURNAL OF CANCER

Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing

(2013) H. Liang et al.   JOURNAL OF IMMUNOLOGY

Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

(2012) T. W. H. Meijer et al.   CLINICAL CANCER RESEARCH

IL-12 family cytokines: immunological playmakers

(2012) Dario A A Vignali et al.   NATURE IMMUNOLOGY

Imaging hypoxia to improve radiotherapy outcome

(2012) Michael R. Horsman et al.   Nature Reviews Clinical Oncology

Dichotomous Effects of IFN-  on Dendritic Cell Function Determine the Extent of IL-12-Driven Antitumor T Cell Immunity

(2011) J. L. Harden et al.   JOURNAL OF IMMUNOLOGY

Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines

(2011) Lovisa Farnebo et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Blockade of Tumor Necrosis Factor   Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy

(2010) Y. Meng et al.   CANCER RESEARCH

Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy

(2010) Tsuguhide Takeshima et al.   CANCER RESEARCH

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

(2009) Y. Lee et al.   BLOOD